Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™

Delray Beach, FL, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The global Medical Plastics Market is projected to grow from USD 34.77 billion in 2026 to USD 48.77 billion by 2031, at a CAGR of 7.0% during the forecast period. Growth is driven by rising demand for advanced medical devices, increasing adoption of minimally invasive procedures, growing preference for single-use and disposable medical products, and expanding pharmaceutical and biotechnology industries.

Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83738633

Key Market Highlights

• Market Size (2026): USD 34.77 Billion
• Projected Market Value (2031): USD 48.77 Billion
• CAGR (2026–2031): 7.0%
• Largest Region: North America
• Fastest-Growing Region: Asia Pacific
• Largest Type: Standard Plastics
• Fastest-Growing Type: High-performance Plastics
• Largest Application: Medical Disposables
• Fastest-Growing Application: Prosthetics & Implants
• Key Players: BASF, Celanese Corporation, SABIC, Covestro AG, Syensqo, Evonik Industries, Arkema, Lubrizol, Ensinger, and Dow.

Why This Market Matters

Medical plastics enable lightweight, biocompatible, sterilizable, and cost-effective medical products. Their growing use in disposable devices, diagnostic equipment, drug delivery systems, implants, and medical packaging is supporting the shift toward advanced healthcare solutions.

Market Overview

The market is expanding alongside healthcare infrastructure, medical device manufacturing, and demand for minimally invasive procedures. Advanced polymers are increasingly being adopted where high mechanical strength, chemical resistance, thermal stability, and sterilization compatibility are required.

Analyst Perspective

The transition toward high-performance, bio-based, recyclable, and antimicrobial medical plastics is creating new opportunities. At the same time, manufacturers must balance sustainability with stringent requirements for biocompatibility, sterilization, safety, and regulatory compliance.

Speak to Our Analyst — Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=83738633

Segment Analysis

• By Type: High-performance plastics are expected to grow at the fastest rate, supported by their use in implants, surgical instruments, catheter components, drug delivery systems, and devices requiring repeated sterilization.
• By Application: Prosthetics & implants are projected to register the fastest growth, driven by increasing surgical volumes, an aging population, and demand for advanced orthopedic, dental, cardiovascular, and spinal implants.

Regional Analysis

North America held the largest market share in 2025, supported by advanced healthcare infrastructure, high healthcare spending, and a strong medical device manufacturing base. Asia Pacific is expected to be the fastest-growing region, driven by expanding healthcare infrastructure, increasing medical device manufacturing, and rising healthcare expenditure.

Key Industry Trends

• Rising adoption of single-use and disposable medical devices
• Growing use of high-performance medical polymers
• Increasing demand for minimally invasive medical devices
• Shift toward bio-based and recyclable medical plastics
• Growing adoption of antimicrobial and sterilization-compatible materials
• Increasing use of advanced polymers in prosthetics, implants, and drug delivery

Competitive Landscape

BASF, Celanese, and SABIC are identified as leading players, supported by strong product portfolios and market presence. Covestro, Syensqo, Evonik, Arkema, Lubrizol, Ensinger, and Dow are also key participants focusing on advanced medical-grade polymers, product innovation, partnerships, and expansion across high-growth medical applications.

Related Reports

Medical Packaging Market

Medical Device Plastics Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/